SpringWorks Therapeutics Inc (NAS:SWTX)
$ 33.52 -0.47 (-1.38%) Market Cap: 2.49 Bil Enterprise Value: 2.15 Bil PE Ratio: 0 PB Ratio: 4.47 GF Score: 41/100

SpringWorks Therapeutics Inc R&D Day (Virtual) Transcript

Jun 10, 2022 / 02:00PM GMT
Release Date Price: $21.86 (-9.93%)
Saqib Islam
SpringWorks Therapeutics, Inc. - CEO & Director

Hello, and welcome to SpringWorks R&D Day. I'm Saqib Islam, CEO of SpringWorks Therapeutics, and I'm delighted to discuss the many exciting opportunities we have to serve a broad range of patients from our portfolio of investigational therapies. Thank you for joining us today.

Before we get started, I'd like to draw your attention to our customary forward-looking statements disclosure. And as a reminder, if you have to leave us early or if you'd like to revisit anything we present here today, a recording and downloadable copy of our R&D Day presentation will be available on our corporate website following the live event.

You'll be hearing today from several members of our team. I'm very pleased to be joined by our Chief Operating Officer, Dr. Badreddin Edris; our Chief Development Officer, Dr. Mary Smith; our Chief Commercial Officer, Bhavesh Ashar; our Head of R&D, Dr. Mike Burgess; and our Chief Medical Officer, Dr. Jim Cassidy. Together, we look forward to sharing our recent accomplishments and discussing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot